Treatment options for PNET liver metastases. a systematic review
01 Pubblicazione su rivista
Nigri Giuseppe, Petrucciani Niccolò, Debs Tarek, Mangogna Livia Maria, Crovetto Anna, Moschetta Giovanni, Persechino Raffaello, Aurello Paolo, Ramacciato Giovanni
ISSN: 1477-7819
Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients with PNET are metastatic at presentation, usually involving the liver (40-93%). Liver metastasis represents the most significant prognostic factor. The aim of this study is to present an up-to-date review of treatment options for patients with liver metastases from PNETs.